331 related articles for article (PubMed ID: 25989851)
21. Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease.
Pienaar IS; Elson JL; Racca C; Nelson G; Turnbull DM; Morris CM
Am J Pathol; 2013 Dec; 183(6):1826-1840. PubMed ID: 24099985
[TBL] [Abstract][Full Text] [Related]
22. The anterior and posterior pedunculopontine tegmental nucleus are involved in behavior and neuronal activity of the cuneiform and entopeduncular nuclei.
Jin X; Schwabe K; Krauss JK; Alam M
Neuroscience; 2016 May; 322():39-53. PubMed ID: 26880033
[TBL] [Abstract][Full Text] [Related]
23. Lesions of cholinergic pedunculopontine tegmental nucleus neurons fail to affect cocaine or heroin self-administration or conditioned place preference in rats.
Steidl S; Wang H; Wise RA
PLoS One; 2014; 9(1):e84412. PubMed ID: 24465410
[TBL] [Abstract][Full Text] [Related]
24. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
[TBL] [Abstract][Full Text] [Related]
25. Altered neuronal activity in the pedunculopontine nucleus: An electrophysiological study in a rat model of Parkinson's disease.
Geng X; Xie J; Wang X; Wang X; Zhang X; Hou Y; Lei C; Li M; Qu Q; He T; Han H; Yao X; Wang M
Behav Brain Res; 2016 May; 305():57-64. PubMed ID: 26924016
[TBL] [Abstract][Full Text] [Related]
26. The Pedunculopontine Tegmental Nucleus is not Important for Breathing Impairments Observed in a Parkinson's Disease Model.
Miranda NC; Oliveira LM; Aquino YC; Moreira TS; Takakura AC
Neuroscience; 2023 Feb; 512():32-46. PubMed ID: 36690033
[TBL] [Abstract][Full Text] [Related]
27. Effect of deep brain stimulation in the pedunculopontine nucleus on motor function in the rat 6-hydroxydopamine Parkinson model.
Rauch F; Schwabe K; Krauss JK
Behav Brain Res; 2010 Jun; 210(1):46-53. PubMed ID: 20138919
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of activating transcription factor 4 induces severe loss of dopamine nigral neurons in a rat model of Parkinson's disease.
Gully JC; Sergeyev VG; Bhootada Y; Mendez-Gomez H; Meyers CA; Zolotukhin S; Gorbatyuk MS; Gorbatyuk OS
Neurosci Lett; 2016 Aug; 627():36-41. PubMed ID: 27233218
[TBL] [Abstract][Full Text] [Related]
29. Excitotoxic lesions of the pedunculopontine tegmental nucleus of the rat. I. Comparison of the effects of various excitotoxins, with particular reference to the loss of immunohistochemically identified cholinergic neurons.
Rugg EL; Dunbar JS; Latimer M; Winn P
Brain Res; 1992 Sep; 589(2):181-93. PubMed ID: 1382812
[TBL] [Abstract][Full Text] [Related]
30. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration.
Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M
Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195
[TBL] [Abstract][Full Text] [Related]
31. Pedunculopontine Nucleus Cholinergic Deficiency in Cervical Dystonia.
Mente K; Edwards NA; Urbano D; Ray-Chaudhury A; Iacono D; Alho ATDL; Alho EJL; Amaro E; Horovitz SG; Hallett M
Mov Disord; 2018 May; 33(5):827-834. PubMed ID: 29508906
[TBL] [Abstract][Full Text] [Related]
32. Rab1A over-expression prevents Golgi apparatus fragmentation and partially corrects motor deficits in an alpha-synuclein based rat model of Parkinson's disease.
Coune PG; Bensadoun JC; Aebischer P; Schneider BL
J Parkinsons Dis; 2011; 1(4):373-87. PubMed ID: 23939344
[TBL] [Abstract][Full Text] [Related]
33. Alterations in Activity-Dependent Neuroprotective Protein in Sporadic and Experimental Parkinson's Disease.
Chu Y; Morfini GA; Kordower JH
J Parkinsons Dis; 2016; 6(1):77-97. PubMed ID: 27003787
[TBL] [Abstract][Full Text] [Related]
34. Deep brain stimulation of the pedunculopontine tegmental nucleus modulates neuronal hyperactivity and enhanced beta oscillatory activity of the subthalamic nucleus in the rat 6-hydroxydopamine model.
Alam M; Heissler HE; Schwabe K; Krauss JK
Exp Neurol; 2012 Jan; 233(1):233-42. PubMed ID: 22036687
[TBL] [Abstract][Full Text] [Related]
35. Cholinergic excitation from the pedunculopontine tegmental nucleus to the dentate nucleus in the rat.
Vitale F; Mattei C; Capozzo A; Pietrantoni I; Mazzone P; Scarnati E
Neuroscience; 2016 Mar; 317():12-22. PubMed ID: 26762800
[TBL] [Abstract][Full Text] [Related]
36. Effects of bilateral vestibular deafferentation in rat on hippocampal theta response to somatosensory stimulation, acetylcholine release, and cholinergic neurons in the pedunculopontine tegmental nucleus.
Aitken P; Zheng Y; Smith PF
Brain Struct Funct; 2017 Sep; 222(7):3319-3332. PubMed ID: 28349227
[TBL] [Abstract][Full Text] [Related]
37. Dopaminergic but not cholinergic neurodegeneration is correlated with gait disturbances in PINK1 knockout rats.
DeAngelo VM; Hilliard JD; McConnell GC
Behav Brain Res; 2022 Jan; 417():113575. PubMed ID: 34534596
[TBL] [Abstract][Full Text] [Related]
38. Continuous stimulation of the pedunculopontine tegmental nucleus at 40 Hz affects preparative and executive control in a delayed sensorimotor task and reduces rotational movements induced by apomorphine in the 6-OHDA parkinsonian rat.
Capozzo A; Vitale F; Mattei C; Mazzone P; Scarnati E
Behav Brain Res; 2014 Sep; 271():333-42. PubMed ID: 24959863
[TBL] [Abstract][Full Text] [Related]
39. Non-invasive evaluation of nigrostriatal neuropathology in a proteasome inhibitor rodent model of Parkinson's disease.
Vernon AC; Johansson SM; Modo MM
BMC Neurosci; 2010 Jan; 11():1. PubMed ID: 20051106
[TBL] [Abstract][Full Text] [Related]
40. Effects of pedunculopontine nucleus cholinergic lesion on gait and dyskinesia in hemiparkinsonian rats.
Chambers NE; Coyle M; Sergio J; Lanza K; Saito C; Topping B; Clark SD; Bishop C
Eur J Neurosci; 2021 Apr; 53(8):2835-2847. PubMed ID: 33426708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
